In this section
@article{Battersby:2018:10.1016/j.earlhmdev.2018.01.017,
author = {Battersby, C and Mousinho, RMA and Longford, N and Modi, N},
doi = {10.1016/j.earlhmdev.2018.01.017},
journal = {EARLY HUMAN DEVELOPMENT},
pages = {32--36},
title = {Use of pasteurised human donor milk across neonatal networks in England},
url = {http://dx.doi.org/10.1016/j.earlhmdev.2018.01.017},
volume = {118},
year = {2018}
}
TY - JOUR
AB - ObjectivesTo describe the use of pasteurised human donor milk (pHDM) in England and the influence of a human milk bank in the network.DesignProspective observational studySettingAll 163 neonatal units (23 networks) in England 2012–2013.PatientsPreterm infants born at <32weeks gestational age (GA).Main outcome measuresProportion of infants and care-days fed pHDM during the first 30 postnatal days by networkMethodsWe extracted daily patient-level data from the National Neonatal Research Database (NNRD). We fitted a logistic regression of pHDM exposure on the presence of a pHDM bank within the network, with GA, BW z score and network as covariates. Significance was assessed by the likelihood ratio (chi-squared) test.ResultsData for 13,463 infants were included in the study. Across the networks, the proportion (95%CI) of infants ranged from 2.0% (1.0, 3.0) to 61.0% (57.4%, 64.6%), and the proportion of care-days in which pHDM was fed from 0.08% (0.04%, 0.10%) to 21.9% (19.9%, 24.0%). In three networks <5%, and in seven networks >30% of infants received any pHDM. Variation in the use of pHDM across networks remained significant after adjustment for presence of a human milk bank within the network and all covariates (p<0.001).ConclusionsWide variation of pHDM use in England is not fully explained by presence of a pHDM bank or patient characteristics. This suggests clinical uncertainty about the use of pHDM.
AU - Battersby,C
AU - Mousinho,RMA
AU - Longford,N
AU - Modi,N
DO - 10.1016/j.earlhmdev.2018.01.017
EP - 36
PY - 2018///
SN - 0378-3782
SP - 32
TI - Use of pasteurised human donor milk across neonatal networks in England
T2 - EARLY HUMAN DEVELOPMENT
UR - http://dx.doi.org/10.1016/j.earlhmdev.2018.01.017
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430033400006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/56319
VL - 118
ER -
Neonatal Medicine Research Group and Neonatal Data Analysis Unit Manager
(All research related queries)
Room G 4.3
Chelsea and Westminster Hospital
ndau@imperial.ac.uk
+44 (0)20 3315 5841
Research Communications Lead
(Communications related queries only)
dsakyi@imperial.ac.uk
